|  Help  |  About  |  Contact Us

Publication : Fractal analysis of amyloid plaques in Alzheimer's disease patients and mouse models.

First Author  Pirici D Year  2011
Journal  Neurobiol Aging Volume  32
Issue  9 Pages  1579-87
PubMed ID  20015575 Mgi Jnum  J:176711
Mgi Id  MGI:5292462 Doi  10.1016/j.neurobiolaging.2009.10.010
Citation  Pirici D, et al. (2011) Fractal analysis of amyloid plaques in Alzheimer's disease patients and mouse models. Neurobiol Aging 32(9):1579-87
abstractText  The varied morphological and biochemical forms in which amyloid deposits in brain of Alzheimer's disease (AD) patients are complex and their mechanisms of formation are not completely understood. Here we investigated the ability of fractal dimension (FD) to differentiate between the textures of commonly observed amyloid plaques in sporadic and familial AD patients and aged-control individuals as well as in transgenic mouse models of amyloidosis. Studying more than 6000 amyloid plaques immunostained for total Abeta (Abetat), Abeta40 or Abeta42, we show here that Abeta40 FD could efficiently differentiate between (i) AD patients and aged-control individuals (P<0.001); (ii) sporadic and familial AD due to presenilin-1 or APP (A692G) mutations (P<0.001); and (iii) three transgenic mouse models of different genotypes (P<0.001). Furthermore, while diffuse and dense-core plaques present in humans and transgenic mice had comparable FDs, both Abetat and Abeta42 FD could also differentiate diffuse plaques from other plaque types in both species (P<0.001). Our data suggest that plaque FD could be a valuable tool for objective, computer-oriented AD diagnosis as well as for genotype-phenotype correlations of AD.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression